As a key Medical Advisor, Jeff Geschwind, MD guides HistoSonics in developing a revolutionary, non-invasive therapy for liver cancer. His expertise is vital in bringing this groundbreaking, image-guided technology to patients worldwide. https://www.scribd.com/document/900578221/Targeting-Tumor-Glycolysis-a-Promising-Frontier-in-Cancer-Therapy